Evidence gaps in the era of Non–Vitamin K oral anticoagulants
KN Aronis, EM Hylek - Journal of the American Heart Association, 2018 - Am Heart Assoc
1920s from studies on the “hemorrhagic” effect of spoiled sweet clover consumption by
cattle1 and have evolved ever since to the cornerstone of oral anticoagulation therapy. The …
cattle1 and have evolved ever since to the cornerstone of oral anticoagulation therapy. The …
[PDF][PDF] Guideline for the management of hypertensive disorders of pregnancy
SA Lowe, L Bowyer, K Lust, LP McMahon… - Society of Obstetric …, 2014 - somanz.org
ABPM Ambulatory blood pressure monitoring AFV Amniotic fluid volume ALT Alanine
transaminase AOR Adjusted odds ratio APPT Activated partial thromboplastin time AST …
transaminase AOR Adjusted odds ratio APPT Activated partial thromboplastin time AST …
[HTML][HTML] Inherited risk factors of thromboembolic events in patients with primary nephrotic syndrome
G Ismail, B Obrișcă, R Jurubiță, A Andronesi… - Medicina, 2020 - mdpi.com
Background and objectives. Venous thromboembolic events (VTEs) are among the most
important complications of nephrotic syndrome (NS). We conducted a study that aimed to …
important complications of nephrotic syndrome (NS). We conducted a study that aimed to …
Use of rivaroxaban in a patient with history of nephrotic syndrome and hypercoagulability
LH Dupree, P Reddy - Annals of Pharmacotherapy, 2014 - journals.sagepub.com
Objective: Hypercoagulability, resulting in thromboembolic events, can be a life-threatening
complication of nephrotic syndrome (NS). Conventional anticoagulants, such as warfarin …
complication of nephrotic syndrome (NS). Conventional anticoagulants, such as warfarin …
Significance of venous thromboembolism in women with cervical cancer
K Matsuo, A Moeini, H Machida, ME Fullerton… - Gynecologic …, 2016 - Elsevier
Objective To characterize risk factors of venous thromboembolism (VTE) and to examine
effects of VTE on survival of women with cervical cancer. Methods This is a retrospective …
effects of VTE on survival of women with cervical cancer. Methods This is a retrospective …
低分子肝素治疗肾病综合征患者高凝状态的实验室观察
但刚， 刘媛， 江忠勇， 胡莉娜， 金静， 耿雪， 吴丽娟 - 重庆医学, 2015 - cqvip.com
目的观察低分子肝素对肾病综合征(NS) 患者继发高凝状态的疗效. 方法将87 例NS
患者分为常规治疗组(n= 42) 和低分子肝素治疗组(n= 45), 应用泼尼松对常规治疗组的患者进行 …
患者分为常规治疗组(n= 42) 和低分子肝素治疗组(n= 45), 应用泼尼松对常规治疗组的患者进行 …
利伐沙班治疗低凝血酶III 的肾病综合征患者静脉血栓栓塞症的疗效
张丽华， 张烔， 田红 - 肾脏病与透析肾移植杂志, 2015 - njcndt.com
目的: 观察利伐沙班治疗肾病综合征伴低抗凝血酶III (AT-III) 血症患者血栓栓塞并发症的临床
疗效与安全性. 方法: 16 例经血管超声, 肾静脉或肺动脉CT 血管造影确诊并发血栓栓塞症的低 …
疗效与安全性. 方法: 16 例经血管超声, 肾静脉或肺动脉CT 血管造影确诊并发血栓栓塞症的低 …
[HTML][HTML] Clinical presentation and management of nephrotic syndrome in the first year of life: a report from the pediatric nephrology research consortium
AR Constantinescu, TK Mattoo, WE Smoyer… - Frontiers in …, 2022 - frontiersin.org
Background and objectives: Nephrotic syndrome (NS) in the first year of life is called
congenital (CNS) if diagnosed between 0-3 months, or infantile (INS) if diagnosed between …
congenital (CNS) if diagnosed between 0-3 months, or infantile (INS) if diagnosed between …
卡托普利联合低分子肝素治疗肾病综合征的临床疗效分析
黄恬 - 检验医学与临床, 2014 - cqvip.com
目的观察卡托普利联合低分子肝素治疗肾病综合征的临床效果. 方法选择本院收治的68
例肾病综合征患者为研究对象. 对照组30 例患者, 给予常规治疗28d; 观察组38 例患者 …
例肾病综合征患者为研究对象. 对照组30 例患者, 给予常规治疗28d; 观察组38 例患者 …
Heparin calcium treated Henoch–Schönlein purpura nephritis in children through inhibiting hyperfibrinolysis
M Tian, C Liu - Renal Failure, 2015 - Taylor & Francis
Aim: To explore the underlying mechanism of low-molecular-weight heparin calcium therapy
on Henoch–Schönlein purpura nephritis (HSPN). Methods: Eighty-nine children with severe …
on Henoch–Schönlein purpura nephritis (HSPN). Methods: Eighty-nine children with severe …